Encysive Pharmaceuticals today announced topline results from the Company’s multi- center, pivotal Phase III STRIDE-2 (Sitaxsentan To Relieve ImpaireD Exercise) trial.
WebProWorld
Encysive Pharmaceuticals today announced topline results from the Company’s multi- center, pivotal Phase III STRIDE-2 (Sitaxsentan To Relieve ImpaireD Exercise) trial.